| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/10/2004 | US6773878 For therapy/drug screening |
| 08/10/2004 | US6773712 Dirofilaria immitis nucleic acid molecule hybridizes in a solution (consisting of sodium chloride, sodium citrate, water, and 0% formamide at 37 degree c., and washing in above solution), to a prefered nucleic acid sequence |
| 08/10/2004 | US6773710 Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis |
| 08/10/2004 | US6773709 Chicken embryo lethal (CELO) virus |
| 08/10/2004 | US6773707 Employing hybrid antigen complex |
| 08/10/2004 | US6773706 Enzymatic polypeptide for use in the diagnosis and treatment of bacterial infections |
| 08/10/2004 | US6773695 Modulation of allergic response |
| 08/10/2004 | CA2457651A1 Antibodies for discrimination of prions |
| 08/10/2004 | CA2145388C Method of controlling polypeptide production in bacteria |
| 08/10/2004 | CA2129101C Synthetic haemophilus influenzae conjugate vaccine |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/05/2004 | WO2004065603A2 Methods for increasing neisseria protein expression |
| 08/05/2004 | WO2004065578A2 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 08/05/2004 | WO2004065575A2 Dna compositon and uses thereof |
| 08/05/2004 | WO2004065558A2 Depletion of endogenous primordial germ cells in avian species |
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | WO2004065409A2 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines |
| 08/05/2004 | WO2004064889A2 Intradermal cellular delivery using narrow gauge micro-cannula |
| 08/05/2004 | WO2004064864A1 Nematode polypeptide adjuvant |
| 08/05/2004 | WO2004064863A1 Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| 08/05/2004 | WO2004064859A1 A hybrid vector system for use as a vaccine |
| 08/05/2004 | WO2004064814A1 Improvements in or relating to anti-aromatase composition |
| 08/05/2004 | WO2004064813A1 Improvements in or relating to anti-aromatase composition |
| 08/05/2004 | WO2004064788A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064787A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | WO2004064784A2 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | WO2004064759A2 Use of tryptanthrin compounds for immune potentiation |
| 08/05/2004 | WO2004064738A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/05/2004 | WO2004055183A3 Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof |
| 08/05/2004 | WO2004047860A3 Cells not presenting antigen for suppressing pathological immune reactions |
| 08/05/2004 | WO2004043405A8 Polysaccharide vaccine for staphylococcal infections |
| 08/05/2004 | WO2004041200A3 Dna based plasmid formulations and vaccines and prophylactics containing the same |
| 08/05/2004 | WO2004041159A3 Composition and method for enhancing immune response of swine |
| 08/05/2004 | WO2004040262A3 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 08/05/2004 | WO2004030614A3 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004009785A3 IgG Fc/HIV-gp120/C3d FUSION PROTEIN |
| 08/05/2004 | WO2004005465A3 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 08/05/2004 | WO2004000238A3 Utilization of mhc class ii binding motifs in immunization to produce immune serum, monoclonal antibodies and vaccines |
| 08/05/2004 | WO2003068144A3 Cytotoxic agents |
| 08/05/2004 | WO2003057842A3 Aggrecanase molecules |
| 08/05/2004 | WO2003048729A3 Discovery of therapeutic products |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2002055548A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 08/05/2004 | US20040152876 Immunogenic HBc chimer particles having enhanced stability |
| 08/05/2004 | US20040152873 Novel gene bn01 mapping to chromosone 16q24.3 |
| 08/05/2004 | US20040152657 Immunomodulatory oligonucleotides |
| 08/05/2004 | US20040152656 For use antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics |
| 08/05/2004 | US20040152649 For prophylaxis and therapy of infectious disease, allergy, cancer |
| 08/05/2004 | US20040152193 Comprises peptide which binds to human leukocyte antigen on surface of cells and can be used as beacon for tissue targeted therapy in tumor cells |
| 08/05/2004 | US20040152192 Apparatus comprising nutrient broth, exogenous cytokines and inhibitor of dipeptidyl dipeptidases for initiating differentiation of hematopoietic cells into antigen specific lymphocytes; cell and gene therapy |
| 08/05/2004 | US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders |
| 08/05/2004 | US20040152179 Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152125 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152077 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 08/05/2004 | US20040152074 Seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/05/2004 | US20040151791 an analgesic selected from morphine, meperidine, fentanyl, hydromorphone, oxymorphone, oxycodone, hydrocodone, methadone, propoxyphene, pentazocine, levorphanol and combinations and a stool softener |
| 08/05/2004 | US20040151779 suspending an active agent-containing powder with active agent hydration less than about 10% in at least one anhydrous, aprotic, hydrophobic, non-polar, low-reactivity vehicle; useful to delivery to an animal for sustained release for long term treatment |
| 08/05/2004 | US20040151740 treating strabismus by administering of a neurotoxic component of a botulinum toxin free of a botulinum toxin complex protein. |
| 08/05/2004 | US20040151737 Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection |
| 08/05/2004 | US20040151736 Use of cross-protection to identify novel vaccine candidates for infectious agents |
| 08/05/2004 | US20040151735 immunogenic and vaccine compositions containing HCV envelope peptide and a HCV non-structural peptide, especially a HCV E1 envelope peptide and a HCV NS3 non-structural peptide |
| 08/05/2004 | US20040151734 Vaccine and method of use |
| 08/05/2004 | US20040151733 at least two conjugated antigens that are glycolipid antigen, polysaccharide antigen, mucin antigen, and/or glycosylated mucin antigen and an adjuvant; especially for treating small cell lung cancer |
| 08/05/2004 | US20040151732 preventing or treating an abdominal aortic aneurysm or rupture by administering an immunosuppressive agent that inhibits T-lymphocyte reactivity with collagen I, collagen III, or epitope thereof; vaccines; determining risk for developing an AAA |
| 08/05/2004 | US20040151731 preventing or treating an abdominal aortic aneurysm or rupture by administering an immunosuppressive agent that inhibits T-lymphocyte reactivity with collagen I, collagen III, or epitope thereof; vaccines; determining risk for developing an AAA |
| 08/05/2004 | US20040151728 fusion polypeptide which can bind to a cell surface binding moiety (e.g., a carbohydrate) and serve as a ligand for a cell surface polypeptide; antigen bearing target such as viral, bacterial, or fungal cells, parasites or prions |
| 08/05/2004 | US20040151726 Novel vaccine for prophylaxis and theraphy in vetirinary and human medicine |
| 08/05/2004 | US20040151723 specific to cancerous and precancerous lesions of the uterus |
| 08/05/2004 | US20040151722 Treatment of metabolic disorders using TNFalpha inhibitors |
| 08/05/2004 | US20040151720 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/05/2004 | US20040151717 Use of polyclonal immunoglobulins |
| 08/05/2004 | US20040151692 administering a substance that can activate CD163 to stimulate the growth, proliferation, differentiation and/or mobilization of a stem cell, e.g., a substance that binds CD163 includes antibodies and CD163 ligands. |
| 08/05/2004 | US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens |
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | CA2648056A1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 08/05/2004 | CA2551442A1 Nematode polypeptide adjuvant |
| 08/05/2004 | CA2514305A1 A hybrid vector system for use as a vaccine |
| 08/05/2004 | CA2513744A1 Depletion of endogenous primordial germ cells in avian species |
| 08/05/2004 | CA2513418A1 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles |
| 08/05/2004 | CA2513331A1 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513320A1 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | CA2513029A1 Intradermal cellular delivery using narrow gauge micro-cannula |
| 08/05/2004 | CA2512917A1 Methods for increasing neisseria protein expression |
| 08/05/2004 | CA2511570A1 Composition and method for preventing or treating a virus infection |
| 08/04/2004 | EP1443112A2 Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/04/2004 | EP1442749A1 Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442124A1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state |
| 08/04/2004 | EP1442114A2 Novel bacterial poultry disease |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |